Literature DB >> 12601120

Juvenile-onset glycogen storage disease type II with novel mutations in acid alpha-glucosidase gene.

C W Lam1, Y P Yuen, K Y Chan, S F Tong, C K Lai, T C Chow, K C Lee, Y W Chan, F Martiniuk.   

Abstract

The authors describe two novel mutations of the acid alpha-glucosidase gene, P361L and R437C, which define the juvenile-onset glycogen storage disease type II (GSDII) in a 16-year-old Chinese patient. The asymptomatic 13-year-old brother of the proband is also a compound heterozygote of the two mutations. These results confirm that intrafamilial phenotypic variation of juvenile-onset GSDII is ethnically diverse and suggest the contribution of other genes to the phenotypic variability of GSDII.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12601120     DOI: 10.1212/01.wnl.0000048661.95327.bf

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  7 in total

1.  Genotype-phenotype correlation of 17 cases of Pompe disease in Spanish patients and identification of 4 novel GAA variants.

Authors:  Paula Hernández-Arévalo; José D Santotoribio; Rocío Delarosa-Rodríguez; Antonio González-Meneses; Salvador García-Morillo; Pilar Jiménez-Arriscado; Juan M Guerrero; Hada C Macher
Journal:  Orphanet J Rare Dis       Date:  2021-05-21       Impact factor: 4.123

2.  Effects of enzyme replacement therapy on five patients with advanced late-onset glycogen storage disease type II: a 2-year follow-up study.

Authors:  Yoshihiko Furusawa; Madoka Mori-Yoshimura; Toshiyuki Yamamoto; Chikako Sakamoto; Mizuki Wakita; Yoko Kobayashi; Yutaka Fukumoto; Yasushi Oya; Tokiko Fukuda; Hideo Sugie; Yukiko K Hayashi; Ichizo Nishino; Ikuya Nonaka; Miho Murata
Journal:  J Inherit Metab Dis       Date:  2011-10-07       Impact factor: 4.982

Review 3.  The natural course of non-classic Pompe's disease; a review of 225 published cases.

Authors:  Léon P F Winkel; Marloes L C Hagemans; Pieter A van Doorn; M Christa B Loonen; Wim J C Hop; Arnold J J Reuser; Ans T van der Ploeg
Journal:  J Neurol       Date:  2005-08       Impact factor: 4.849

4.  Assessing metabolic profiles in human myoblasts from patients with late-onset Pompe disease.

Authors:  Peter Meinke; Sarah Limmer; Stefan Hintze; Benedikt Schoser
Journal:  Ann Transl Med       Date:  2019-07

5.  Uptake of moss-derived human recombinant GAA in Gaa -/- mice.

Authors:  Stefan Hintze; Paulina Dabrowska-Schlepp; Birgit Berg; Alexandra Graupner; Andreas Busch; Andreas Schaaf; Benedikt Schoser; Peter Meinke
Journal:  JIMD Rep       Date:  2021-02-01

6.  Identification of Seven Novel Mutations in the Acid Alpha-glucosidase Gene in Five Chinese Patients with Late-onset Pompe Disease.

Authors:  Hua-Xu Liu; Chuan-Qiang Pu; Qiang Shi; Yu-Tong Zhang; Rui Ban
Journal:  Chin Med J (Engl)       Date:  2018-02-20       Impact factor: 2.628

7.  Moss-Derived Human Recombinant GAA Provides an Optimized Enzyme Uptake in Differentiated Human Muscle Cells of Pompe Disease.

Authors:  Stefan Hintze; Sarah Limmer; Paulina Dabrowska-Schlepp; Birgit Berg; Nicola Krieghoff; Andreas Busch; Andreas Schaaf; Peter Meinke; Benedikt Schoser
Journal:  Int J Mol Sci       Date:  2020-04-10       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.